\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ t\\=35\\.9\\,\\ p\\=63\\,\\ r\\=20\\ bp\\=106\\/41\ \(0\)\
\-\ pt\\ is\\ follows\\ simple\\ commands\\,\\ continues\\ to\\ be\\ non\\-verbal\\,\\ perrla\\,\\ neurological\\ exam\\ is\\ grossly\\ intact\\.\\ \\ pt\\ does\\ not\\ appear\\ to\\ be\\ in\\ pain\\.\\ \\ chest\\ and\\ lung\\ exam\\ are\\ unremarkable\\,\\ no\\ apparent\\ abdominal\\ pain\\ or\\ change\\ in\\ bowel\\ or\\ bladder\\ habits\\.\\ \\ the\\ pt\\ has\\ numerous\\ scars\\ on\\ her\\ extremities\\,\\ sebaceous\\ adenomas\\ on\\ her\\ face\\,\\ as\\ well\\ as\\ a\\ shagreen\\ patch\\ on\\ her\\ forehead\\.\\ \\ there\\ are\\ areas\\ of\\ cutaneous\\ hyperpigmentation\\ on\\ her\\ back\\.\\ \ \(0\)\
\-\ cbc\\,\\ chem\\ 7\\,\\ and\\ lfts\\ are\\ all\\ normal\\.\ \(0\)\
\-\ the\\ main\\ complication\\ of\\ tuberous\\ sclerosis\\ requiring\\ long\\ term\\ therapy\\ is\\ seizure\\ disorders\\,\\ as\\ was\\ this\\ case\\ with\\ our\\ patient\\.\\ \\ she\\ was\\ placed\\ on\\ antiepileptic\\ medication\\ and\\ has\\ spent\\ much\\ of\\ her\\ childhood\\ in\\ institutions\\ due\\ to\\ her\\ behavioral\\ and\\ developmental\\ delays\\ as\\ well\\ as\\ poor\\ family\\ support\\.\\ \\ in\\ oct\\ 2006\\ she\\ had\\ a\\ peg\\ tube\\ placed\\ for\\ poor\\ feeding\\ and\\ is\\ being\\ closely\\ monitored\\ by\\ her\\ pcp\\ and\\ a\\ neurologist\\.\\ \\ standards\\ currently\\ suggest\\ follow\\-up\\ mris\\ every\\ 1\\-3\\ years\\ in\\ children\\ with\\ tuberous\\ sclerosis\\.\\ options\\ for\\ treatment\\ outside\\ of\\ antiepileptic\\ medications\\ include\\ immunosuppressive\\ therapy\\,\\ surgical\\ resection\\ such\\ as\\ focal\\ cortical\\ resection\\,\\ corpus\\ callosotomy\\ \\,\\ or\\ vagal\\ stimulation\\.\\ \\ since\\ subependymal\\ giant\\ cell\\ astrocytomas\\ are\\ associated\\ with\\ tuberous\\ sclerosis\\ and\\ can\\ cause\\ hydrocephalus\\,\\ surgical\\ resection\\ may\\ be\\ indicated\\.\ \(0\)\
\-\ mri\\ of\\ the\\ brain\\ w\\/o\\ iv\\ contrast\\.\\ \\ the\\ \\ ventricles\\ \\ are\\ increased\\ \\ slightly\\ \\ in\\ \\ size\\ \\ which\\ most\\ likely\\ represents\\ \\ mild\\ \\ atrophy\\.\\ \\ \\ \\ approximately\\ six\\ subependymal\\ lesions\\ \\ are\\ \\ identified\\ \\ in\\ the\\ lateral\\ ventricles\\ bilaterally\\ with\\ enhancement\\ \\ of\\ \\ the\\ \\ largest\\ \\ lesion\\ \\ in\\ \\ the\\ right\\ \\ lateral\\ \\ ventricle\\ \\ which\\ \\ measures\\ \\ approximately\\ \\ 1\\.1\\ \\ cm\\ \\ in\\ \\ its\\ greatest\\ \\ diameter\\.\\ \\ \\ these\\ appear\\ unchanged\\ from\\ previous\\ studies\\.\\ \\ \\ noted\\ \\ are\\ \\ the\\ \\ multiple\\ \\ areas\\ \\ of\\ \\ abnormal\\ \\ t2\\ \\ prolongation\\ \\ scattered\\ \\ throughout\\ \\ the\\ cerebral\\ \\ hemispheres\\.\\ \\ \\ \\ these\\ \\ are\\ \\ grossly\\ \\ unchanged\\ \\ when\\ compared\\ \\ with\\ previous\\ \\ studies\\.\\ \\ \\ there\\ is\\ no\\ increase\\ \\ in\\ \\ the\\ extra\\-axial\\ \\ fluid\\.\\ \\ \\ \\ there\\ \\ is\\ \\ no\\ \\ evidence\\ \\ of\\ \\ cerebellar\\ \\ ectopia\\.\\ \\ \\ \\ the\\ anterior\\ \\ pituitary\\ \\ is\\ noted\\ \\ to\\ \\ be\\ \\ concaved\\ \\ but\\ \\ is\\ \\ grossly\\ \\ unchanged\\ \\ when\\ \\ compared\\ \\ with\\ \\ previous\\ \\ studies\\.\\ \\ \\ \\ the\\ \\ corpus\\ \\ callosum\\ \\ is\\ \\ somewhat\\ \\ thin\\.\ \(0\)\
\-\ tuberous\\ sclerosis\\ \\(bourneville\\ disease\\)\ \(0\)\
\-\ complex\\ partial\\ seizures\\ \ \(2\)\
\-\ epilepsy\\ with\\ mental\\ retardation\\ \ \(0\)\
\-\ tuberous\\ sclerosis\ \(40\)\
\-\ glioblastoma\\ multiforme\\ \ \(1\)\
\-\ hydrocephalus\\ \ \(74\)\
\-\ infantile\\ spasm\\ \\(west\\ syndrome\\)\\ \ \(0\)\
\-\ lennox\\-gastaut\\ syndrome\\ \ \(0\)\
\-\ giant\\ cell\\ astrocytoma\ \(5\)\
\-\ 16\\ y\\/o\\ white\\ female\\ presented\\ to\\ the\\ er\\ with\\ her\\ mother\\ with\\ c\\/o\\ increasing\\ seizure\\ activity\\,\\ increased\\ self\\-mutilation\\,\\ and\\ violence\\ towards\\ others\\.\\ \\ pt\\ has\\ longstanding\\ hx\\ of\\ problems\\ since\\ birth\\ to\\ include\\ autism\\,\\ mental\\ retardation\\ and\\ developmental\\ delay\\,\\ as\\ well\\ as\\ sz\\ disorder\\.\\ the\\ pt\\ is\\ non\\-verbal\\.\\ the\\ patient\\ was\\ being\\ followed\\ at\\ another\\ facility\\,\\ however\\,\\ due\\ to\\ a\\ recent\\ move\\,\\ her\\ family\\ now\\ wishes\\ to\\ have\\ her\\ care\\ managed\\ at\\ your\\ facility\ \(0\)\
\-\ as\\ is\\ the\\ case\\ with\\ more\\ than\\ 90\\ percent\\ of\\ patients\\ with\\ tuberous\\ sclerosis\\,\\ this\\ patient\\ presented\\ with\\ seizures\\.\\ \\ though\\ her\\ underlying\\ hx\\ of\\ seizures\\ disorder\\ complicates\\ the\\ picture\\,\\ it\\ is\\ likely\\ that\\ some\\ of\\ the\\ problems\\ she\\ is\\ having\\ are\\ manifestations\\ of\\ her\\ tuberous\\ sclerosis\\.\\ \\ in\\ addition\\,\\ this\\ patient\\,\\ like\\ 50\\-85\\ percent\\ of\\ those\\ affected\\ by\\ tuberous\\ sclerosis\\,\\ had\\ severe\\ developmental\\ delay\\.\\ \\ she\\ also\\ had\\ the\\ skin\\ manifestation\\ that\\ are\\ characteristic\\ in\\ more\\ than\\ 80\\ percent\\ of\\ patient\\'s\\ to\\ include\\ shagreen\\ patches\\ and\\ sebaceous\\ adenomas\\ on\\ her\\ face\\.\\ \\ this\\ patient\\'s\\ condition\\ was\\ being\\ managed\\ conservatively\\ with\\ antiepileptic\\ medication\\ and\\ routine\\ follow\\-up\\ mris\\.\\ interestingly\\,\\ within\\ the\\ past\\ year\\ the\\ patient\\ also\\ had\\ renal\\ us\\ done\\ due\\ to\\ possible\\ renal\\ cysts\\ versus\\ tumors\\,\\ which\\ can\\ be\\ found\\ in\\ up\\ to\\ 80\\ percent\\ of\\ patients\\ with\\ tuberous\\ sclerosis\\.\\ \\ however\\,\\ at\\ the\\ time\\ of\\ this\\ posting\\,\\ the\\ final\\ results\\ are\\ not\\ known\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tuberous\\:\\ 0\\.06574813825797932\ \(0\)\
\-\ her\\:\\ 0\\.05186700552842261\ \(0\)\
\-\ sclerosis\\:\\ 0\\.04289415698887749\ \(0\)\
\-\ antiepileptic\\:\\ 0\\.03356869803508881\ \(0\)\
\-\ percent\\:\\ 0\\.02892320087333432\ \(0\)\
\-\ unchanged\\:\\ 0\\.025069244811248535\ \(0\)\
\-\ pt\\:\\ 0\\.024667420455223233\ \(0\)\
\-\ non\\-verbal\\:\\ 0\\.02396554700403226\ \(0\)\
\-\ shagreen\\:\\ 0\\.02396554700403226\ \(0\)\
\-\ grossly\\:\\ 0\\.020891855979876556\ \(0\)\
\-\ are\\:\\ 0\\.019896913971778913\ \(0\)\
\-\ sebaceous\\:\\ 0\\.018967292617590954\ \(0\)\
\-\ mris\\:\\ 0\\.018967292617590954\ \(0\)\
\-\ developmental\\:\\ 0\\.018499990702676588\ \(0\)\
\-\ as\\:\\ 0\\.018063971355663278\ \(0\)\
\-\ retardation\\:\\ 0\\.017922347783363584\ \(0\)\
\-\ adenomas\\:\\ 0\\.017639826733035244\ \(0\)\
\-\ seizures\\:\\ 0\\.017114230749055145\ \(0\)\
\-\ subependymal\\:\\ 0\\.015844553904540964\ \(0\)\
\-\ previous\\:\\ 0\\.015458153099409766\ \(0\)\
\-\ she\\:\\ 0\\.01489929280406318\ \(0\)\
\-\ studies\\:\\ 0\\.014867240300213478\ \(0\)\
\-\ facility\\:\\ 0\\.014510508377562004\ \(0\)\
\-\ managed\\:\\ 0\\.014273325213634756\ \(0\)\
\-\ being\\:\\ 0\\.013871683121741732\ \(0\)\
\-\ medication\\:\\ 0\\.013368505954812572\ \(0\)\
\-\ delay\\:\\ 0\\.013170209457959985\ \(0\)\
\-\ hx\\:\\ 0\\.013138356972968713\ \(0\)\
\-\ corpus\\:\\ 0\\.01307561564589567\ \(0\)\
\-\ \\,\\:\\ 0\\.013031074582353896\ \(0\)\
\-\ face\\:\\ 0\\.013014116803360952\ \(0\)\
\-\ giant\\:\\ 0\\.012779621298677272\ \(0\)\
\-\ t\\=35\\.9\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ p\\=63\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ r\\=20\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ bp\\=106\\/41\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ callosotomy\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ concaved\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ self\\-mutilation\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ posting\\:\\ 0\\.012612377707153032\ \(0\)\
\-\ ventricles\\:\\ 0\\.012483626951458871\ \(0\)\
\-\ 80\\:\\ 0\\.012483626951458871\ \(0\)\
\-\ resection\\:\\ 0\\.012414203364224621\ \(0\)\
\-\ mental\\:\\ 0\\.01238262325050993\ \(0\)\
\-\ problems\\:\\ 0\\.012284801303120577\ \(0\)\
\-\ bourneville\\:\\ 0\\.01198277350201613\ \(0\)\
\-\ violence\\:\\ 0\\.01198277350201613\ \(0\)\
\-\ sz\\:\\ 0\\.01198277350201613\ \(0\)\
\-\ 50\\-85\\:\\ 0\\.01198277350201613\ \(0\)\
\-\ poor\\:\\ 0\\.011943183616119558\ \(0\)\
\-\ disorder\\:\\ 0\\.011921691557596035\ \(0\)\
\-\ seizure\\:\\ 0\\.011734676464449903\ \(0\)\
\-\ standards\\:\\ 0\\.011536062209389141\ \(0\)\
\-\ immunosuppressive\\:\\ 0\\.011536062209389141\ \(0\)\
\-\ lennox\\-gastaut\\:\\ 0\\.011536062209389141\ \(0\)\
\-\ autism\\:\\ 0\\.011536062209389141\ \(0\)\
\-\ wishes\\:\\ 0\\.011536062209389141\ \(0\)\
\-\ complicates\\:\\ 0\\.011536062209389141\ \(0\)\
\-\ had\\:\\ 0\\.011452483349321169\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.011409487166036764\ \(0\)\
\-\ is\\:\\ 0\\.011350590246896636\ \(0\)\
\-\ compared\\:\\ 0\\.011232985691616995\ \(0\)\
\-\ behavioral\\:\\ 0\\.011189566011696269\ \(0\)\
\-\ include\\:\\ 0\\.011166864074675249\ \(0\)\
\-\ hyperpigmentation\\:\\ 0\\.01090645800425224\ \(0\)\
\-\ delays\\:\\ 0\\.01090645800425224\ \(0\)\
\-\ peg\\:\\ 0\\.01090645800425224\ \(0\)\
\-\ family\\:\\ 0\\.010876746723368667\ \(0\)\
\-\ appear\\:\\ 0\\.010861485807833172\ \(0\)\
\-\ placed\\:\\ 0\\.010742025308367967\ \(0\)\
\-\ institutions\\:\\ 0\\.010667093594582585\ \(0\)\
\-\ due\\:\\ 0\\.010622409097606396\ \(0\)\
\-\ spent\\:\\ 0\\.01045974671162525\ \(0\)\
\-\ vagal\\:\\ 0\\.01045974671162525\ \(0\)\
\-\ habits\\:\\ 0\\.010276853799115339\ \(0\)\
\-\ be\\:\\ 0\\.010231030460744792\ \(0\)\
\-\ patches\\:\\ 0\\.00983014250648835\ \(0\)\
\-\ since\\:\\ 0\\.009747716216454087\ \(0\)\
\-\ 1\\-3\\:\\ 0\\.009705852587740623\ \(0\)\
\-\ epilepsy\\:\\ 0\\.009705852587740623\ \(0\)\
\-\ west\\:\\ 0\\.009705852587740623\ \(0\)\
\-\ commands\\:\\ 0\\.009590778096818695\ \(0\)\
\-\ prolongation\\:\\ 0\\.00938343121386136\ \(0\)\
\-\ patient\\:\\ 0\\.009310781857786825\ \(0\)\
\-\ neurologist\\:\\ 0\\.009289293602345159\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.00920053830135145\ \(0\)\
\-\ patch\\:\\ 0\\.009116582988819965\ \(0\)\
\-\ well\\:\\ 0\\.009005035495195579\ \(0\)\
\-\ areas\\:\\ 0\\.008929649600143063\ \(0\)\
\-\ scars\\:\\ 0\\.00888893784255929\ \(0\)\
\-\ your\\:\\ 0\\.00888893784255929\ \(0\)\
\-\ chem\\:\\ 0\\.008819913366517622\ \(0\)\
\-\ oct\\:\\ 0\\.008819913366517622\ \(0\)\
\-\ longstanding\\:\\ 0\\.008819913366517622\ \(0\)\
\-\ interestingly\\:\\ 0\\.008819913366517622\ \(0\)\
\-\ lfts\\:\\ 0\\.00875382700872446\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.008633655252924664\ \(0\)\
\-\ forehead\\:\\ 0\\.008629537089976732\ \(0\)\
\-\ ectopia\\:\\ 0\\.008629537089976732\ \(0\)\
\-\ infantile\\:\\ 0\\.008629537089976732\ \(0\)\
\-\ perrla\\:\\ 0\\.008570934096214547\ \(0\)\
\-\ move\\:\\ 0\\.008570934096214547\ \(0\)\
\-\ manifestation\\:\\ 0\\.008570934096214547\ \(0\)\
\-\ in\\:\\ 0\\.0085064658258126\ \(0\)\
\-\ pcp\\:\\ 0\\.008407330811031587\ \(0\)\
\-\ stimulation\\:\\ 0\\.008259333637422386\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.008259333637422386\ \(0\)\
\-\ towards\\:\\ 0\\.008212978104581268\ \(0\)\
\-\ approximately\\:\\ 0\\.00821061436818504\ \(0\)\
\-\ closely\\:\\ 0\\.007999932884839831\ \(0\)\
\-\ monitored\\:\\ 0\\.007999932884839831\ \(0\)\
\-\ renal\\:\\ 0\\.007973526551112015\ \(0\)\
\-\ others\\:\\ 0\\.007812622344795399\ \(0\)\
\-\ c\\/o\\:\\ 0\\.007777726605894687\ \(0\)\
\-\ picture\\:\\ 0\\.007777726605894687\ \(0\)\
\-\ cutaneous\\:\\ 0\\.007710203140149751\ \(0\)\
\-\ multiforme\\:\\ 0\\.007710203140149751\ \(0\)\
\-\ 2006\\:\\ 0\\.007645493984248247\ \(0\)\
\-\ when\\:\\ 0\\.007600407570236042\ \(0\)\
\-\ syndrome\\:\\ 0\\.007589771977436774\ \(0\)\
\-\ manifestations\\:\\ 0\\.007553221592212842\ \(0\)\
\-\ largest\\:\\ 0\\.007523643649711764\ \(0\)\
\-\ w\\/o\\:\\ 0\\.007494618598450658\ \(0\)\
\-\ likely\\:\\ 0\\.007485372565017566\ \(0\)\
\-\ has\\:\\ 0\\.007475310421557195\ \(0\)\
\-\ childhood\\:\\ 0\\.007466126147102526\ \(0\)\
\-\ this\\:\\ 0\\.007462245444985505\ \(0\)\
\-\ spasm\\:\\ 0\\.007438147101290914\ \(0\)\
\-\ which\\:\\ 0\\.007430797766657836\ \(0\)\
\-\ however\\:\\ 0\\.007389341787568541\ \(0\)\
\-\ conservatively\\:\\ 0\\.0073836574742547805\ \(0\)\
\-\ requiring\\:\\ 0\\.007331015313267698\ \(0\)\
\-\ greatest\\:\\ 0\\.007331015313267698\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.0073053486953310355\ \(0\)\
\-\ to\\:\\ 0\\.007294641603839828\ \(0\)\
\-\ presented\\:\\ 0\\.007234029922429842\ \(0\)\
\-\ cell\\:\\ 0\\.007168449414849336\ \(0\)\
\-\ final\\:\\ 0\\.007159667398409212\ \(0\)\
\-\ follows\\:\\ 0\\.007136662606817378\ \(0\)\
\-\ support\\:\\ 0\\.00711399366361683\ \(0\)\
\-\ therapy\\:\\ 0\\.0070951577523000395\ \(0\)\
\-\ hemispheres\\:\\ 0\\.00706962507286519\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.00706962507286519\ \(0\)\
\-\ every\\:\\ 0\\.007047907305823668\ \(0\)\
\-\ than\\:\\ 0\\.006953567872416999\ \(0\)\
\-\ continues\\:\\ 0\\.006923617387075942\ \(0\)\
\-\ these\\:\\ 0\\.006906349975024348\ \(0\)\
\-\ patients\\:\\ 0\\.0068682440974100175\ \(0\)\
\-\ atrophy\\:\\ 0\\.0068459614545065915\ \(0\)\
\-\ feeding\\:\\ 0\\.006808542896154012\ \(0\)\
\-\ callosum\\:\\ 0\\.006808542896154012\ \(0\)\
\-\ on\\:\\ 0\\.006744326202162374\ \(0\)\
\-\ pituitary\\:\\ 0\\.006650495234182052\ \(0\)\
\-\ more\\:\\ 0\\.00663719350718064\ \(0\)\
\-\ simple\\:\\ 0\\.006537807822947835\ \(0\)\
\-\ six\\:\\ 0\\.0065223569986416745\ \(0\)\
\-\ somewhat\\:\\ 0\\.0065223569986416745\ \(0\)\
\-\ complication\\:\\ 0\\.006507058401680476\ \(0\)\
\-\ increased\\:\\ 0\\.006492188763352968\ \(0\)\
\-\ options\\:\\ 0\\.006447328151947874\ \(0\)\
\-\ represents\\:\\ 0\\.006375758109711435\ \(0\)\
\-\ birth\\:\\ 0\\.006375758109711435\ \(0\)\
\-\ vitals\\:\\ 0\\.006348028890146207\ \(0\)\
\-\ disorders\\:\\ 0\\.006348028890146207\ \(0\)\
\-\ our\\:\\ 0\\.006307341976490891\ \(0\)\
\-\ versus\\:\\ 0\\.006307341976490891\ \(0\)\
\-\ noted\\:\\ 0\\.006290127914449048\ \(0\)\
\-\ 90\\:\\ 0\\.0062546998155038076\ \(0\)\
\-\ main\\:\\ 0\\.006178938691017112\ \(0\)\
\-\ scattered\\:\\ 0\\.006178938691017112\ \(0\)\
\-\ though\\:\\ 0\\.006154484720569691\ \(0\)\
\-\ much\\:\\ 0\\.0061424006515602885\ \(0\)\
\-\ like\\:\\ 0\\.0061424006515602885\ \(0\)\
\-\ was\\:\\ 0\\.006138369703190601\ \(0\)\
\-\ having\\:\\ 0\\.006094983378485628\ \(0\)\
\-\ term\\:\\ 0\\.006071806902993895\ \(0\)\
\-\ mother\\:\\ 0\\.006060347109053487\ \(0\)\
\-\ those\\:\\ 0\\.00603767816585294\ \(0\)\
\-\ can\\:\\ 0\\.006019324075990899\ \(0\)\
\-\ 16\\:\\ 0\\.006004283437248959\ \(0\)\
\-\ numerous\\:\\ 0\\.005950173605990934\ \(0\)\
\-\ cbc\\:\\ 0\\.0059290468170844456\ \(0\)\
\-\ there\\:\\ 0\\.0059241407909859725\ \(0\)\
\-\ medications\\:\\ 0\\.005918590245374284\ \(0\)\
\-\ apparent\\:\\ 0\\.005867338232224952\ \(0\)\
\-\ \\'s\\:\\ 0\\.00585107645455604\ \(0\)\
\-\ exam\\:\\ 0\\.005829919068166267\ \(0\)\
\-\ case\\:\\ 0\\.005805914387786554\ \(0\)\
\-\ neurological\\:\\ 0\\.005741497844021341\ \(0\)\
\-\ indicated\\:\\ 0\\.005741497844021341\ \(0\)\
\-\ affected\\:\\ 0\\.005741497844021341\ \(0\)\
\-\ lateral\\:\\ 0\\.005734993930511026\ \(0\)\
\-\ children\\:\\ 0\\.0057322273983901224\ \(0\)\
\-\ cerebellar\\:\\ 0\\.005723011970564324\ \(0\)\
\-\ another\\:\\ 0\\.005704743583018382\ \(0\)\
\-\ underlying\\:\\ 0\\.0056866876233986315\ \(0\)\
\-\ measures\\:\\ 0\\.005677737771353989\ \(0\)\
\-\ suggest\\:\\ 0\\.005651193620174952\ \(0\)\
\-\ addition\\:\\ 0\\.005625095610366906\ \(0\)\
\-\ characteristic\\:\\ 0\\.005616492845808498\ \(0\)\
\-\ tube\\:\\ 0\\.005590966873225951\ \(0\)\
\-\ diameter\\:\\ 0\\.005582550619391573\ \(0\)\
\-\ surgical\\:\\ 0\\.005578328479041781\ \(0\)\
\-\ outside\\:\\ 0\\.005565853737751415\ \(0\)\
\-\ increase\\:\\ 0\\.005565853737751415\ \(0\)\
\-\ us\\:\\ 0\\.005565853737751415\ \(0\)\
\-\ condition\\:\\ 0\\.005549334485880211\ \(0\)\
\-\ done\\:\\ 0\\.005500805691619179\ \(0\)\
\-\ thin\\:\\ 0\\.00545374769550842\ \(0\)\
\-\ increasing\\:\\ 0\\.005438373361684333\ \(0\)\
\-\ at\\:\\ 0\\.005393306612569719\ \(0\)\
\-\ bladder\\:\\ 0\\.00538573120069725\ \(0\)\
\-\ slightly\\:\\ 0\\.005363705369964398\ \(0\)\
\-\ results\\:\\ 0\\.005356432312025848\ \(0\)\
\-\ routine\\:\\ 0\\.005320569400854033\ \(0\)\
\-\ complex\\:\\ 0\\.005313495151574746\ \(0\)\
\-\ partial\\:\\ 0\\.005306452985168859\ \(0\)\
\-\ currently\\:\\ 0\\.0052580322903913925\ \(0\)\
\-\ also\\:\\ 0\\.005231737868540843\ \(0\)\
\-\ extremities\\:\\ 0\\.005204482327547963\ \(0\)\
\-\ cysts\\:\\ 0\\.005197916588247463\ \(0\)\
\-\ change\\:\\ 0\\.005171927780241992\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.005152717699803255\ \(0\)\
\-\ skin\\:\\ 0\\.005096473501923878\ \(0\)\
\-\ er\\:\\ 0\\.005090348069794972\ \(0\)\
\-\ 7\\:\\ 0\\.005084246706223714\ \(0\)\
\-\ its\\:\\ 0\\.00500703640288143\ \(0\)\
\-\ tumors\\:\\ 0\\.004984031611289598\ \(0\)\
\-\ activity\\:\\ 0\\.0049783332745054944\ \(0\)\
\-\ ventricle\\:\\ 0\\.00497265577263731\ \(0\)\
\-\ throughout\\:\\ 0\\.004966998953881873\ \(0\)\
\-\ the\\:\\ 0\\.004937474453700921\ \(0\)\
\-\ intact\\:\\ 0\\.004873858108227044\ \(0\)\
\-\ iv\\:\\ 0\\.0048422747476103934\ \(0\)\
\-\ cortical\\:\\ 0\\.004837072749341323\ \(0\)\
\-\ care\\:\\ 0\\.004785989358802411\ \(0\)\
\-\ identified\\:\\ 0\\.004741408449047082\ \(0\)\
\-\ or\\:\\ 0\\.004665478644240874\ \(0\)\
\-\ cerebral\\:\\ 0\\.004596966617646072\ \(0\)\
\-\ that\\:\\ 0\\.004583791082480818\ \(0\)\
\-\ long\\:\\ 0\\.004574878122411061\ \(0\)\
\-\ now\\:\\ 0\\.004535893772828645\ \(0\)\
\-\ does\\:\\ 0\\.004527361910534171\ \(0\)\
\-\ cause\\:\\ 0\\.004489538239987525\ \(0\)\
\-\ possible\\:\\ 0\\.004468916488950422\ \(0\)\
\-\ recent\\:\\ 0\\.00446074386465807\ \(0\)\
\-\ size\\:\\ 0\\.004448565017668899\ \(0\)\
\-\ followed\\:\\ 0\\.004448565017668899\ \(0\)\
\-\ by\\:\\ 0\\.004418853736785325\ \(0\)\
\-\ white\\:\\ 0\\.004400782938993816\ \(0\)\
\-\ unremarkable\\:\\ 0\\.004392960277456615\ \(0\)\
\-\ back\\:\\ 0\\.00437743219774453\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004358237948018483\ \(0\)\
\-\ past\\:\\ 0\\.0042161482483640276\ \(0\)\
\-\ known\\:\\ 0\\.004198837087676739\ \(0\)\
\-\ found\\:\\ 0\\.004181716792627503\ \(0\)\
\-\ bowel\\:\\ 0\\.00416141852932416\ \(0\)\
\-\ such\\:\\ 0\\.004148032282361572\ \(0\)\
\-\ severe\\:\\ 0\\.004082779192649075\ \(0\)\
\-\ some\\:\\ 0\\.0040293916985508675\ \(0\)\
\-\ no\\:\\ 0\\.004008280205141935\ \(0\)\
\-\ brain\\:\\ 0\\.00399278186848255\ \(0\)\
\-\ years\\:\\ 0\\.00389634027487342\ \(0\)\
\-\ lung\\:\\ 0\\.0038434147829794194\ \(0\)\
\-\ not\\:\\ 0\\.003834840595471849\ \(0\)\
\-\ focal\\:\\ 0\\.0037895863418298164\ \(0\)\
\-\ abnormal\\:\\ 0\\.003784304720985887\ \(0\)\
\-\ fluid\\:\\ 0\\.0037711787338569145\ \(0\)\
\-\ t2\\:\\ 0\\.003755572622283155\ \(0\)\
\-\ all\\:\\ 0\\.0037529867848311964\ \(0\)\
\-\ time\\:\\ 0\\.003747827992607628\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0036748897978565844\ \(0\)\
\-\ up\\:\\ 0\\.003568085638282955\ \(0\)\
\-\ cm\\:\\ 0\\.003558938071144388\ \(0\)\
\-\ enhancement\\:\\ 0\\.0035566595747252108\ \(0\)\
\-\ lesions\\:\\ 0\\.003552112587490602\ \(0\)\
\-\ mild\\:\\ 0\\.003494182381880647\ \(0\)\
\-\ evidence\\:\\ 0\\.003478948110818133\ \(0\)\
\-\ anterior\\:\\ 0\\.003417380161122263\ \(0\)\
\-\ abdominal\\:\\ 0\\.0033166447796927254\ \(0\)\
\-\ pain\\:\\ 0\\.003241019153822157\ \(0\)\
\-\ chest\\:\\ 0\\.003175045031145215\ \(0\)\
\-\ associated\\:\\ 0\\.0031311530464405305\ \(0\)\
\-\ of\\:\\ 0\\.0030754108906301293\ \(0\)\
\-\ and\\:\\ 0\\.0030746879861093214\ \(0\)\
\-\ most\\:\\ 0\\.0030634086051678196\ \(0\)\
\-\ mri\\:\\ 0\\.003048564992103447\ \(0\)\
\-\ it\\:\\ 0\\.002982683826914622\ \(0\)\
\-\ contrast\\:\\ 0\\.002970148581999853\ \(0\)\
\-\ may\\:\\ 0\\.0029104477777921176\ \(0\)\
\-\ have\\:\\ 0\\.0028733510533619435\ \(0\)\
\-\ but\\:\\ 0\\.0028299740699278533\ \(0\)\
\-\ multiple\\:\\ 0\\.0027947298190671875\ \(0\)\
\-\ female\\:\\ 0\\.002727888620260611\ \(0\)\
\-\ lesion\\:\\ 0\\.0027027255062118858\ \(0\)\
\-\ treatment\\:\\ 0\\.0026857406204982715\ \(0\)\
\-\ with\\:\\ 0\\.0025435690454323856\ \(0\)\
\-\ within\\:\\ 0\\.0025312599509100643\ \(0\)\
\-\ a\\:\\ 0\\.0024633528063267157\ \(0\)\
\-\ for\\:\\ 0\\.00226431102062955\ \(0\)\
\-\ \\(\\:\\ 0\\.0022433593982728586\ \(0\)\
\-\ \\)\\:\\ 0\\.00221595556556927\ \(0\)\
\-\ disease\\:\\ 0\\.0021688471136889816\ \(0\)\
\-\ normal\\:\\ 0\\.002080143563042082\ \(0\)\
\-\ from\\:\\ 0\\.001966515082537597\ \(0\)\
\-\ \\.\\:\\ 0\\.0017639521042159638\ \(0\)\
\-\ \\:\\:\\ 0\\.001755085117997927\ \(0\)\
\-\ year\\:\\ 0\\.0014846355112933458\ \(0\)\
\-\ right\\:\\ 0\\.001400049237749094\ \(0\)\
